These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25318863)

  • 1. Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation.
    MacManus MP; Ball D; Hicks RJ
    Radiat Oncol; 2014 Oct; 9():217. PubMed ID: 25318863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.
    Dang J; Li G; Zang S; Zhang S; Yao L
    Radiat Oncol; 2014 Jul; 9():172. PubMed ID: 25074618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer.
    Sheng L; Cui X; Cheng L; Chen Y; Du X
    Radiat Oncol; 2019 Dec; 14(1):229. PubMed ID: 31842910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
    Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
    Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    Tang C; Lee MS; Gomez D; Levy LB; Zhuang Y; Lu C; Liao Z; Komaki R
    Am J Clin Oncol; 2017 Dec; 40(6):625-630. PubMed ID: 26165417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.
    Yegya-Raman N; Reyhan M; Kim S; Deek MP; Yue N; Zou W; Malhotra J; Aisner J; Jabbour SK
    Pract Radiat Oncol; 2019 Jan; 9(1):e74-e82. PubMed ID: 30144583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.
    Palma DA; Senan S; Tsujino K; Barriger RB; Rengan R; Moreno M; Bradley JD; Kim TH; Ramella S; Marks LB; De Petris L; Stitt L; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):444-50. PubMed ID: 22682812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy comparison between microwave ablation combined with radiation therapy and radiation therapy alone for locally advanced nonsmall-cell lung cancer.
    Song P; Sun W; Pang M; He W; Zhang W; Sheng L
    J Cancer Res Ther; 2021 Jul; 17(3):715-719. PubMed ID: 34269304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
    Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
    Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
    Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
    Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.
    Amin NP; Miften M; Thornton D; Ryan N; Kavanagh B; Gaspar LE
    Med Dosim; 2013; 38(3):320-6. PubMed ID: 23611631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
    Vogelius IS; Westerly DC; Cannon GM; Mackie TR; Mehta MP; Sugie C; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):893-9. PubMed ID: 21477946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
    Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
    Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Challenging Case of Radiation-Induced Lung Fibrosis.
    Sahu KK; Mishra AK; Noreldin M
    Am J Med; 2020 Oct; 133(10):1158-1161. PubMed ID: 32289303
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
    Katsui K; Ogata T; Watanabe K; Katayama N; Kuroda M; Kiura K; Hiraki T; Maeda Y; Toyooka S; Kanazawa S
    Cancer Med; 2020 Jul; 9(13):4540-4549. PubMed ID: 32364685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.